Why I'm praying assisted dying bill passes major vote - even though it's not going to happen in my lifetime
On Friday, the social fabric of England and Wales might be changed forever.
MPs are set to vote on the assisted dying bill and supporters are confident that they have the numbers to win.
But the hugely controversial legislation polarises opinion. Communities remain divided, and medical colleagues can't agree.
Three royal colleges have withdrawn support for the bill in its current form. They want more time to be given for further scrutiny of the legislation.
1:12
Frank Sutton does not have time. When we went to Frank's home in East Dulwich, London, last November to watch the vote unfold she already had terminal liver disease and cancer.
As the vote was passed with a majority of 55, Frank broke down in tears and said: "Finally, I can die in peace."
Frank is unlikely to live long enough to see assisted dying introduced in England and Wales. If the legislation passes, it will be introduced in four years.
Frank now suffers from diabetes and fibromyalgia.
She said: "On top of everything I've got, to start developing more comorbidities, I have a massive thought in my head, which I live with every day, which is, is my body, am I on the road to the end, you know, is my body just giving up?
"I mean, I was taking morphine anyway for pain, but now I'm living on morphine, and that's not a life that you want."
But even as MPs prepare to vote, many important questions remain over who will take responsibility for determining a patient's mental capacity and their prognosis. The Royal College of Psychiatrists said it was approaching Friday "with trepidation".
Dr Annabel Price, the RCPsych's lead on assisted dying, told Sky News: "If this bill as it stands proceeds through the rest of the parliamentary process, we as psychiatrists are left in a situation where there are so many unknowns about what is expected of us, about what patients can expect and about the safety of the process.
"We will continue to engage and there may be opportunities for reconsideration at further points in the bill. But yes, I approach this professionally with trepidation."
The Royal College of GPs says the assisted dying process should happen outside of general practice.
Dr Susi Caesar is in favour of the bill being passed and feels it is okay for the medical community to be so divided on the issue.
She said: "I think people have the right to make their own choices and absolutely I would not want to see anybody forced into being part of this process who didn't. Our current system is broken and this law would go a long way towards fixing it, at least for a certain group of people."
1:43
But the Royal Colleges of Physicians (RCP) also has reservations about the bill in its current form.
It says it would be hard for a panel of experts who have no connection to a patient requesting an assisted death to determine if the person is being coerced or has mental capacity.
Dr John Dean, clinical vice president at the RCP has concerns, saying: "Currently decisions clearly are made by patients but agreed by single doctors and then the social worker and psychiatrists are not meeting the patient and those that have been caring for them.
"This has to be done in keeping with modern clinical practice which is complex decisions made with patients and families by teams."
But for patients like Frank, these concerns have not changed her mind.
She said: "I'm praying for Friday that it still goes through because, like I said, it's not going to happen in my lifetime, but the thought that people like me who still try to look nice, who still tried to have a life and everything, that they can just have some peace of mind and they can have a weight lifted off their shoulders knowing that they're going to be able to do it peacefully with their family."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
6 minutes ago
- Daily Mail
EXCLUSIVE Revealed, the NHS hospital trusts plagued by abnormally high deaths. Is YOURS on the list of the worst affected?
Five NHS trusts are plagued by abnormally high death rates, MailOnline can today reveal. Our investigation into hospitals suggests thousands of 'excess' fatalities may have occurred between them. Your browser does not support iframes. Your browser does not support iframes. Your browser does not support iframes. Your browser does not support iframes. Your browser does not support iframes. Your browser does not support iframes. Your browser does not support iframes.
Sky News
6 hours ago
- Sky News
Why I'm praying assisted dying bill passes major vote - even though it's not going to happen in my lifetime
On Friday, the social fabric of England and Wales might be changed forever. MPs are set to vote on the assisted dying bill and supporters are confident that they have the numbers to win. But the hugely controversial legislation polarises opinion. Communities remain divided, and medical colleagues can't agree. Three royal colleges have withdrawn support for the bill in its current form. They want more time to be given for further scrutiny of the legislation. 1:12 Frank Sutton does not have time. When we went to Frank's home in East Dulwich, London, last November to watch the vote unfold she already had terminal liver disease and cancer. As the vote was passed with a majority of 55, Frank broke down in tears and said: "Finally, I can die in peace." Frank is unlikely to live long enough to see assisted dying introduced in England and Wales. If the legislation passes, it will be introduced in four years. Frank now suffers from diabetes and fibromyalgia. She said: "On top of everything I've got, to start developing more comorbidities, I have a massive thought in my head, which I live with every day, which is, is my body, am I on the road to the end, you know, is my body just giving up? "I mean, I was taking morphine anyway for pain, but now I'm living on morphine, and that's not a life that you want." But even as MPs prepare to vote, many important questions remain over who will take responsibility for determining a patient's mental capacity and their prognosis. The Royal College of Psychiatrists said it was approaching Friday "with trepidation". Dr Annabel Price, the RCPsych's lead on assisted dying, told Sky News: "If this bill as it stands proceeds through the rest of the parliamentary process, we as psychiatrists are left in a situation where there are so many unknowns about what is expected of us, about what patients can expect and about the safety of the process. "We will continue to engage and there may be opportunities for reconsideration at further points in the bill. But yes, I approach this professionally with trepidation." The Royal College of GPs says the assisted dying process should happen outside of general practice. Dr Susi Caesar is in favour of the bill being passed and feels it is okay for the medical community to be so divided on the issue. She said: "I think people have the right to make their own choices and absolutely I would not want to see anybody forced into being part of this process who didn't. Our current system is broken and this law would go a long way towards fixing it, at least for a certain group of people." 1:43 But the Royal Colleges of Physicians (RCP) also has reservations about the bill in its current form. It says it would be hard for a panel of experts who have no connection to a patient requesting an assisted death to determine if the person is being coerced or has mental capacity. Dr John Dean, clinical vice president at the RCP has concerns, saying: "Currently decisions clearly are made by patients but agreed by single doctors and then the social worker and psychiatrists are not meeting the patient and those that have been caring for them. "This has to be done in keeping with modern clinical practice which is complex decisions made with patients and families by teams." But for patients like Frank, these concerns have not changed her mind. She said: "I'm praying for Friday that it still goes through because, like I said, it's not going to happen in my lifetime, but the thought that people like me who still try to look nice, who still tried to have a life and everything, that they can just have some peace of mind and they can have a weight lifted off their shoulders knowing that they're going to be able to do it peacefully with their family."
BBC News
8 hours ago
- BBC News
Breakthrough Alzheimer's drugs too pricey to be offered on NHS
Two breakthrough Alzheimer's drugs have been deemed far too expensive, for too little benefit, to be offered on the medicines are the first to slow the disease, which may give people extra time living National Institute for Health and Care Excellence (NICE) concluded they were a poor use of taxpayers' money and said funding them could lead to other services being say it is a disappointment, but dementia experts have also supported the decision. The two drugs, donanemab and lecanemab, both help the body clear a gungy protein that builds up in the brains of people with Alzheimer's medicines do not reverse or even stop the disease, rather brain power is lost more slowly with trials of these drugs were celebrated as a scientific triumph as they showed, for the first time, it was possible to change the course of Alzheimer' since then a row has developed over the cost of the drugs and how meaningful the benefit is. The official price in the US is £20,000-£25,000 per patient per year. What the NHS would pay is 70,000 people in England with mild dementia would have been eligible, potentially putting the bill in the region of £1.5bn a year for the drugs resources, including regularly infusing the drugs directly into spinal fluid and frequent brain scans to manage dangerous side effects, would also massively ramp up the cost. The benefit of the drugs is also debated. They potentially delay the transition from mild to moderate dementia by four-to-six months. That could mean more time without needing daily care, driving, being present for significant family events and Prof Rob Howard, from University College London, said real-world benefits "were too small to be noticeable". In trials of lecanemab, patients were better off by 0.45 points, on an 18-point scale ranging from healthy to severe he said the cost would "have been close to the cost of a nurse's salary for each treated patient".The decision not to fund the drugs is not a surprise. The first assessment last year concluded they were not Knight, director of medicines evaluation at NICE, acknowledged the latest news would be "disappointing" but said the benefits were "modest" at best while requiring "substantial resources"."If they were approved they could displace other essential treatments and services that deliver significant benefits to patients," she said. NICE said its appraisal had factored in potential savings in the cost of providing care, but the drugs were still deemed decisions apply to the NHS in England, but are normally adopted by Wales and Northern Ireland too. Scotland has its own method for approving pharmaceutical companies have three weeks to raise concerns about how the review was performed, otherwise the decision becomes final on 23 pharmaceutical companies involved, Eisai for lecanemab and Eli Lilly for donanemab, say they will appeal against the decision. Nick Burgin, from Eisai said the NHS "is not ready" for the challenge of tackling Alzheimer's and flaws in the process meant their drug would have been rejected "even if Eisai provided lecanemab to the NHS for free".Eli Lilly, the company behind donanemab, has already expressed its disappointment. "If the system can't deliver scientific firsts to NHS patients, it is broken," said Chris Stokes, Eli Lilly's president and general manager of UK and Northern Europe. Is this a distraction or a disappointment? The sentiment was echoed by both the Alzheimer's charities. Prof Fiona Carragher, from the Alzheimer's Society said "the science is flying but the system is failing" and it was "highly disappointing" the drugs were not available on the Evans-Newton, the chief executive at Alzheimer's Research UK, said the result was "painful" and patients will miss out on this and future innovations "not because science is failing, but because the system is".However, others say NICE has made the right call. Tom Dening, professor of dementia research at the University of Nottingham, said he was "in complete support" as the benefits of the drugs were "minimal" and a "distraction" from the real issues in dementia."[Namely the] unglamorous challenge of providing people with dementia and their families with activities, care and support that we already know are beneficial for their mental and physical health," he Atticus Hainsworth, from St George's, University of London, said: "NICE is simply doing its job."Beyond lecanemab and donenamab there are 138 dementia medicines being tested in 182 trials around the Tara Spires-Jones, director of the centre for discovery brain sciences at the University of Edinburgh, said: "There is hope for safer, more effective treatments on the horizon."
